| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
764 |
753 |
$75K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,087 |
1,077 |
$62K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
421 |
417 |
$22K |
| 99050 |
|
714 |
710 |
$12K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
421 |
418 |
$12K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
243 |
200 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
65 |
65 |
$5K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
440 |
439 |
$4K |
| 0072A |
|
44 |
44 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
53 |
53 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
45 |
45 |
$920.25 |
| 94760 |
|
403 |
401 |
$884.84 |
| 0001A |
|
18 |
18 |
$825.84 |
| 96127 |
|
64 |
64 |
$647.01 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
49 |
49 |
$503.23 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15 |
15 |
$177.15 |